This page lists the various grants and awards currently available from Spinal Research
Basic science research grants usually three years in duration. These grants are available to international researchers.
Strategy grants form the mainstay of our basic science programme and are normally awarded following an internationally-advertised competitive call for proposals based on themes identified by our Scientific Advisory Committee with reference to our research strategy discussion document. Calls for project proposals are advertised in published academic journals. Project grants are generally for the support of a postdoctoral researcher to undertake the approved research plan over a period of up to three years, plus necessary consumables, travel or technical assistance. Support will also be considered for equipment if essential to the project.
Available to principle investigators in UK research institutions. Three (3) year awards that include highly competitive stipend and consumables budget. These calls are not usually themed.
These awards are aimed at encouraging the development of talented, highly-motivated young scientists in the field of spinal cord repair, in both clinical and basic science research environments. Calls for project proposals are advertised in published academic journals. The successful project supervisor is responsible for recruiting a suitable post graduate candidate. The PhD degree must be awarded from a UK university and a high priority is given to collaborative proposals between more than one laboratory or institution.
Support includes University fees, a stipend in line with that offered by the Wellcome Trust, plus funds for consumables, travel costs and IT equipment. Typically, the PhD student is recruited to a team that is already established in the field of spinal cord injury research, where they will receive an excellent quality of training and support. As well as obligations within their own institution, all students are encouraged to attend and present their data at research conferences and to attend our annual Research Network Meeting.
Two year grants focused on translational activities aimed at addressing scientific and technical hurdles on the critical path to the clinic. These grants are not expected to be rich in new hypothesis.
Grants will be awarded to support the translation from the laboratory into the clinic of promising new treatments for spinal cord injury. Candidate treatments should already have demonstrated efficacy in a peer-reviewed publication in at least one in vivo spinal injury model, and should involve a clinically-feasible delivery procedure. Funding is designed to bring promising treatments to a stage that they are ready for first-in-man studies, and will provide support for preclinical studies of the following example types: dose-response, toxicity and studies of the optimum therapeutic windows; optimisation of delivery methods; assessment in additional spinal injury models. Support for phase I clinical trials and clinical feasibility trails will also be considered. Funding through this scheme will not be available for projects where the primary aim(s) are to examine mechanisms of action, test novel therapeutic concepts or establish proof of principle. Milestones that are demonstrably on the critical path to the clinic are essential and will have a strong bearing on the success of the application. Applicants will be expected to have considered possible primary and secondary clinical outcomes and the target patient cohort.